Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to…
Read More
Aflibercept Won’t Help Vision in Early Diabetic Retinopathy
Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS,…
Read More
A single injection reverses blindness in patient with rare genetic disorder
A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye. The clinical trial was conducted by researchers at…
Read More
A new blindness gene uncovered in a canine study
Inherited retinal dystrophy is a common cause of blindness, with as many as two million people suffering from the disorder globally. No effective treatment is available for retinal dystrophies. Gene therapy is expected to offer a solution, but developing such…
Read More
Blooms the Chemist Metformin XR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BLOOMS THE CHEMIST METFORMIN XR Contains the active ingredient metformin hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this…
Read More